Leukotrienes mediate delayed airway effects of 15-HETE.
Schellenberg
R R
RR
University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.
Tsang
S
S
Salari
H
H
D001980:Bronchi / Q000378:metabolism; D016084:Bronchoconstriction; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism* / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis / Q000378:metabolism*; D009000:Monocytes / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects; D011422:Propionates / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D002722:Chlorobenzenes
D006893:Hydroxyeicosatetraenoic Acids; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D011422:Propionates; D011804:Quinolines; C060893:MK-886; D002722:Chlorobenzenes; C059141:verlukast; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid